Medicare Enrolled

Dr. Teresa Sosenko

Rheumatology · Morton Grove, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
9000 WAUKEGAN RD STE 200, Morton Grove, IL 60053
8473753000
In practice since 2016 (10 years)
NPI: 1326400169 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sosenko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sosenko? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sosenko

Dr. Teresa Sosenko is a rheumatology specialist in Morton Grove, IL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Sosenko performed 93,371 Medicare services across 4,115 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sosenko received a total of $15,671 from 10 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sosenko is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 11% volume in IL $15,671 industry payments

Medicare Practice Summary

Medicare Utilization ↗
93,371
Medicare services
Top 11% in IL for rheumatology
4,115
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,337 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 46,830 $8 $25
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
31,200 $4 $13
Denosumab injection (Prolia/Xgeva) 7,800 $19 $59
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
780 $1 $3
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
763 $17 $86
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
743 $11 $151
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
573 $97 $285
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
561 $8 $19
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
424 $3 $31
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
424 $5 $50
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
351 $10 $67
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
288 $8 $47
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
255 $6 $20
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
214 $11 $81
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
203 $29 $207
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
185 $122 $377
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $65 $205
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
154 $62 $354
Rheumatoid factor level 135 $6 $45
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
130 $13 $89
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
113 $147 $400
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
110 $39 $352
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
109 $13 $118
Measurement of dna antibody, single stranded 109 $12 $97
New patient office visit, complex (60-74 min) 107 $182 $495
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
105 $51 $441
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
89 $4 $31
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
82 $33 $137
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
52 $32 $144
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
49 $60 $232
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
36 $44 $220
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
35 $61 $170
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
32 $58 $233
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
26 $32 $129
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
25 $6 $40
Screening test for antibody to noninfectious agent
A laboratory test that screens for the presence of antibodies produced in response to a noninfectious agent.
24 $12 $40
Hyaluronan intra-articular injection
An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning.
21 $563 $1,793
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
15 $98 $295
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $94 $255
X-ray of middle spine, 2 views
An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints.
13 $27 $149
X-ray of both hips, 3-4 views
An X-ray imaging test that captures 3 to 4 views of both hip joints to visualize the bones and surrounding structures.
12 $44 $196
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
94.0% medium
5.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,671
Total received (2018-2024)
Avg $2,612/year across 6 years
Top 15% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
84
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,115 (90.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,556 (9.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,572
2023
$5,247
2022
$516
2021
$133
2019
$11
2018
$193

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$9,081
Amgen Inc.
$363
Radius Health, Inc.
$74
UCB, Inc.
$41
Genentech USA, Inc.
$13
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$9,354
AbbVie Inc.
$4,901
Amgen Inc.
$668
Horizon Therapeutics plc
$324
PFIZER INC.
$193
Radius Health, Inc.
$74
UCB, Inc.
$71
Novartis Pharmaceuticals Corporation
$61
Genentech USA, Inc.
$13
Novo Nordisk Inc
$11
Top 3 companies account for 95.2% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · CHANTIX · COSENTYX · Cimzia · ELIQUIS · EVENITY · Enbrel · KRYSTEXXA · Otezla · RINVOQ · SKYRIZI · Tavneos · Tymlos · Victoza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Morton Grove?
Compare rheumatologists in the Morton Grove area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
164
Per 100K population
3.2
County median income
$81,797
Nearest hospital
ADVOCATE LUTHERAN GENERAL HOSPITAL
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sosenko is a mixed practice specialist, with above-average Medicare volume (top 11% in IL), with speaking/promotional industry engagement in the top 15% of IL peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sosenko experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Sosenko performed 46,830 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sosenko receive payments from pharmaceutical companies?
Yes. Dr. Sosenko received a total of $15,671 from 10 companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sosenko's costs compare to other rheumatologists in Morton Grove?
Dr. Sosenko's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sosenko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →